ArticleBMJ public health2026
Frailty among adult people living with HIV in Tanzania: a single-centred hospital-based cross-sectional study.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Frailty is recognised as a significant health challenge among adults living with HIV. The increasing ageing population in more than 21.1 million people living with HIV (PLHIV) in Eastern and Southern Africa is of public health concern; however, data on the prevalence and associated factors of frailty in this population are limited. This study aimed to determine the prevalence of pre-frailty, frailty, identify associated factors and assess its impact on quality of life (QoL) among adult PLHIV attending Muhimbili National Hospital in Tanzania. Methods: A hospital-based, cross-sectional study was done in 2023 at the Care and Treatment Clinic (CTC). Adult PLHIV aged 35 years and above were enrolled using a linear systematic sampling. Frailty was assessed using the FRAIL scale which measured fatigue, resistance, ambulation, illnesses and loss of weight, where scores of 3-5, 1-2 and 0 indicated frailty, pre-frailty and healthy, respectively. WHOQOL-HIV BREF instrument measured QoL scores (4-20) using physical, psychological, level of independence, social relationships, environmental health and belief domains. Factors associated with frailty were determined using ordinal logistic regression. Comparison of QoL scores between frailty groups was determined using one-way Analysis of Variance (ANOVA). Statistical significance was set at p<0.05. Results: A total of 268 PLHIV were included with a mean age of 51.8±10.0 years. Prevalence of pre-frailty and frailty was 23.5% and 27.6%, respectively. Factors associated with frailty included older age (≥50 years), being female and ever being diagnosed with a mental disorder. The QoL score was 16.2±1.6. Low scores in physical health and level of independence domains were significantly associated with increasing frailty severity status. Conclusion: More than 50% of adult PLHIV had pre-frailty and frailty status. This is a multifactorial condition not solely a consequence of HIV infection itself. Its association with reduced QoL highlights the importance of integrating routine frailty screening into CTC care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.